Zobrazeno 1 - 1
of 1
pro vyhledávání: '"BH Carlos"'
Autor:
HR Kenneth, BH Carlos, T Alastair, HZ Amy, RS Akshara, MK Rashmi, T Debu, L Bora, GH Sharon, UT Naoto, V Vicente, C-M Mariana, MA Elizabeth, LK Jennifer
Publikováno v:
Cancer Research. 78:P5-20
Background: Pertuzumab (P) in combination with trastuzumab (H) based chemotherapy is currently FDA- approved as a standard neoadjuvant treatment for patients with clinical stage II-III HER2-positive (HER2+) breast cancer (BC). The chemotherapy backbo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d8855d7cebd044eea46fbc376dac92f
https://doi.org/10.1158/1538-7445.sabcs17-p5-20-10
https://doi.org/10.1158/1538-7445.sabcs17-p5-20-10
